Back

Combined pulsed field and radiofrequency ablation for ventricular tachycardia ablation: a safety, efficacy and comparative study

12 April 2026 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Workflows in ventricular tachycardia ablation Ablation of Ventricular Arrhythmias EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Tc So

Queen Elizabeth Hospital, Hong Kong (Hong Kong)

6 More presentations in this session

Presentation thumbnail
Integrating multipolar and wavefront annotation with computed tomography-derived wall thinning analysis to identify critical substrate in scar-related ventricular tachycardia
Doctor M. Hachisuka (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Photon-counting CT characterization of arrhythmogenic substrate in VT ablation
Doctor S. Valcher (Rozzano, IT)
Abstract Slides Video
Presentation thumbnail
Substrate ablation by dechanneling technique in elderly patients
Doctor E. Silva Garcia (Sevilla, ES)
Abstract Slides Video
Presentation thumbnail
Feasibility of retrograde coronary venous ethanol ablation for ventricular arrhythmias in patients with persistent left superior vena cava
Doctor H. Lopez Martinez (Houston, US)
Abstract Slides Video
Presentation thumbnail
Bipolar epi-endocardial radiofrequency ablation of ventricular tachycardia
Doctor V. Maslova (Kiel, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Workflows in ventricular tachycardia ablation

The Event

Event poster

EHRA 2026

12 April - 14 April 2026
You may be interested in
thumbnail
Congress Presentation
Focal pulsed field ablation for ventricular tachycardia in ischemic heart disease: a case series
thumbnail
Congress Presentation
Revisiting ventricular tachycardia ablation: insights into pulsed field energy. A systematic review and meta-analysis of prospective studies
thumbnail
Congress Presentation
High-voltage pulsed field ablation: a novel strategy for multiple redo ventricular tachycardia ablation in nonischemic cardiomyopathy patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources